Global Elasomeran 麻豆原创 Research Report 2025

Publication ID:

PB504256184

Publication Date:

April 23, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

The global market for Elasomeran was valued at US$ 428 million in the year 2024 and is projected to reach a revised size of US$ 339 million by 2031, growing at a CAGR of -2.2% during the forecast period.
Elasomeran is an mRNA vaccine developed collaboratively by the National Institute of Allergy and Infectious Diseases (NIAID) and Moderna Inc., primarily designed to prevent COVID-19 infection. The vaccine works by delivering mRNA encoding the viral spike protein into human cells, prompting the cells to produce this protein and thereby stimulating the immune system to mount a defense against the virus. Elasomeran has received approval in multiple countries and is widely used in COVID-19 vaccination programs. 鈥�
North American market for Elasomeran is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Elasomeran is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Elasomeran include Moderna, RECIPHARM, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Elasomeran, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Elasomeran.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Elasomeran competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
The Elasomeran market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Elasomeran market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Elasomeran manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Moderna
RECIPHARM
Segment by Type
Vial
Prefilled
Segment by Application
Hospital
Immunization Agency
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Elasomeran manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Elasomeran in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Elasomeran 麻豆原创 Overview
1.1 Product Definition
1.2 Elasomeran by Type
1.2.1 Global Elasomeran 麻豆原创 Value Comparison by Type (2024 VS 2031)
1.2.2 Vial
1.2.3 Prefilled
1.3 Elasomeran by Application
1.3.1 Global Elasomeran 麻豆原创 Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Immunization Agency
1.4 Global Elasomeran 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Elasomeran Revenue 2020-2031
1.4.2 Global Elasomeran Sales 2020-2031
1.4.3 Global Elasomeran 麻豆原创 Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Elasomeran 麻豆原创 Competition by Manufacturers
2.1 Global Elasomeran Sales 麻豆原创 Share by Manufacturers (2020-2025)
2.2 Global Elasomeran Revenue 麻豆原创 Share by Manufacturers (2020-2025)
2.3 Global Elasomeran Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Elasomeran, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Elasomeran, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Elasomeran, Product Type & Application
2.7 Global Key Manufacturers of Elasomeran, Date of Enter into This Industry
2.8 Global Elasomeran 麻豆原创 Competitive Situation and Trends
2.8.1 Global Elasomeran 麻豆原创 Concentration Rate
2.8.2 The Global 5 and 10 Largest Elasomeran Players 麻豆原创 Share by Revenue
2.8.3 Global Elasomeran Company Type and 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Elasomeran 麻豆原创 Scenario by Region
3.1 Global Elasomeran 麻豆原创 Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Elasomeran Sales by Region: 2020-2031
3.2.1 Global Elasomeran Sales by Region: 2020-2025
3.2.2 Global Elasomeran Sales by Region: 2026-2031
3.3 Global Elasomeran Revenue by Region: 2020-2031
3.3.1 Global Elasomeran Revenue by Region: 2020-2025
3.3.2 Global Elasomeran Revenue by Region: 2026-2031
3.4 North America Elasomeran 麻豆原创 Facts & Figures by Country
3.4.1 North America Elasomeran 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Elasomeran Sales by Country (2020-2031)
3.4.3 North America Elasomeran Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Elasomeran 麻豆原创 Facts & Figures by Country
3.5.1 Europe Elasomeran 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Elasomeran Sales by Country (2020-2031)
3.5.3 Europe Elasomeran Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Elasomeran 麻豆原创 Facts & Figures by Region
3.6.1 Asia Pacific Elasomeran 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Elasomeran Sales by Region (2020-2031)
3.6.3 Asia Pacific Elasomeran Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Elasomeran 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Elasomeran 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Elasomeran Sales by Country (2020-2031)
3.7.3 Latin America Elasomeran Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Elasomeran 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Elasomeran 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Elasomeran Sales by Country (2020-2031)
3.8.3 Middle East and Africa Elasomeran Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Elasomeran Sales by Type (2020-2031)
4.1.1 Global Elasomeran Sales by Type (2020-2025)
4.1.2 Global Elasomeran Sales by Type (2026-2031)
4.1.3 Global Elasomeran Sales 麻豆原创 Share by Type (2020-2031)
4.2 Global Elasomeran Revenue by Type (2020-2031)
4.2.1 Global Elasomeran Revenue by Type (2020-2025)
4.2.2 Global Elasomeran Revenue by Type (2026-2031)
4.2.3 Global Elasomeran Revenue 麻豆原创 Share by Type (2020-2031)
4.3 Global Elasomeran Price by Type (2020-2031)
5 Segment by Application
5.1 Global Elasomeran Sales by Application (2020-2031)
5.1.1 Global Elasomeran Sales by Application (2020-2025)
5.1.2 Global Elasomeran Sales by Application (2026-2031)
5.1.3 Global Elasomeran Sales 麻豆原创 Share by Application (2020-2031)
5.2 Global Elasomeran Revenue by Application (2020-2031)
5.2.1 Global Elasomeran Revenue by Application (2020-2025)
5.2.2 Global Elasomeran Revenue by Application (2026-2031)
5.2.3 Global Elasomeran Revenue 麻豆原创 Share by Application (2020-2031)
5.3 Global Elasomeran Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Moderna
6.1.1 Moderna Company Information
6.1.2 Moderna Description and Business Overview
6.1.3 Moderna Elasomeran Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Moderna Elasomeran Product Portfolio
6.1.5 Moderna Recent Developments/Updates
6.2 RECIPHARM
6.2.1 RECIPHARM Company Information
6.2.2 RECIPHARM Description and Business Overview
6.2.3 RECIPHARM Elasomeran Sales, Revenue and Gross Margin (2020-2025)
6.2.4 RECIPHARM Elasomeran Product Portfolio
6.2.5 RECIPHARM Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Elasomeran Industry Chain Analysis
7.2 Elasomeran Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Elasomeran Production Mode & Process Analysis
7.4 Elasomeran Sales and 麻豆原创ing
7.4.1 Elasomeran Sales Channels
7.4.2 Elasomeran Distributors
7.5 Elasomeran Customer Analysis
8 Elasomeran 麻豆原创 Dynamics
8.1 Elasomeran Industry Trends
8.2 Elasomeran 麻豆原创 Drivers
8.3 Elasomeran 麻豆原创 Challenges
8.4 Elasomeran 麻豆原创 Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Moderna
RECIPHARM

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.